{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:22:53Z","timestamp":1793798573218,"version":"4.6.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.pedneo.2022.10.001","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T11:38:37Z","timestamp":1666784317000},"page":"S10-S17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"S1","title":["Current and new therapies for mucopolysaccharidoses"],"prefix":"10.1016","volume":"64","author":[{"given":"Monica","family":"Penon-Portmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Harmatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2022.10.001_bib1","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012836","article-title":"The rapidly evolving view of lysosomal storage diseases","volume":"13","author":"Parenti","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.pedneo.2022.10.001_bib2","article-title":"Prevalence of lysosomal storage disorders in Australia from 2009 to 2020","volume":"19","author":"Chin","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"issue":"Sect Study Dis Child","key":"10.1016\/j.pedneo.2022.10.001_bib4","first-page":"104","article-title":"A rare disease in two brothers","volume":"10","author":"Hunter","year":"1917","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.pedneo.2022.10.001_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.680836","article-title":"Glycosaminoglycans: from vascular physiology to tissue engineering applications","volume":"9","author":"Lepedda","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.pedneo.2022.10.001_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fcell.2020.00731","article-title":"Distribution and function of glycosaminoglycans and proteoglycans in the development, homeostasis and pathology of the ocular surface","volume":"8","author":"Puri","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"Pt B","key":"10.1016\/j.pedneo.2022.10.001_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.expneurol.2015.08.004","article-title":"\u201cGAG-ing with the neuron\u201d: the role of glycosaminoglycan patterning in the central nervous system","volume":"274","author":"Smith","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pedneo.2022.10.001_bib64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ymgme.2016.01.012","article-title":"Elevated TNF-\u03b1 is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI","volume":"117","author":"Polgreen","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2022.10.001_bib73","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ymgme.2018.07.001","article-title":"Critical review of current MPS guidelines and management","volume":"126","author":"Stapleton","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2022.10.001_bib12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/S1462399408000550","article-title":"The mucopolysaccharidoses: a success of molecular medicine","volume":"10","author":"Clarke","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.pedneo.2022.10.001_bib13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.162.3853.570","article-title":"Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts","volume":"162","author":"Fratantoni","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.pedneo.2022.10.001_bib14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1073\/pnas.64.1.360","article-title":"The defect in Hurler and Hunter syndromes, II. Deficiency of specific factors involved in mucopolysaccharide degradation","volume":"64","author":"Fratantoni","year":"1969","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pedneo.2022.10.001_bib16","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.pedneo.2022.10.001_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler\u2019s disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.pedneo.2022.10.001_bib18","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pedneo.2022.10.001_bib19","first-page":"65","article-title":"Molecular Genetics and Metabolism Report long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements","volume":"2","author":"Yasuda","year":"2015","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.pedneo.2022.10.001_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10545-016-0006-2","article-title":"Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience","volume":"40","author":"Rodgers","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.pedneo.2022.10.001_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-016-0470-7","article-title":"Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation","volume":"11","author":"Schmidt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pedneo.2022.10.001_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13023-020-01644-w","article-title":"Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)","volume":"16","author":"Guffon","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pedneo.2022.10.001_bib24","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","article-title":"Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines","volume":"21","author":"Aldenhoven","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.pedneo.2022.10.001_bib25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2017.5","article-title":"Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome","volume":"52","author":"Lum","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.pedneo.2022.10.001_bib26","first-page":"31","article-title":"Bone marrow transplantation in Hunter syndrome: a preliminary report","volume":"22","author":"Warkentin","year":"1986","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.pedneo.2022.10.001_bib27","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbmt.2017.06.020","article-title":"Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis II","volume":"23","author":"Kubaski","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.pedneo.2022.10.001_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/2326409818779097","article-title":"Hematopoietic stem cell transplantation in mucopolysaccharidosis type II: a literature review and critical analysis","volume":"6","author":"Barth","year":"2018","journal-title":"J Inborn Errors Metab Screen"},{"key":"10.1016\/j.pedneo.2022.10.001_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00710053","article-title":"Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation","volume":"18","author":"Shapiro","year":"1995","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.pedneo.2022.10.001_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years","volume":"154","author":"Guffon","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2022.10.001_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","article-title":"Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan","volume":"107","author":"Tanaka","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2022.10.001_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2014.11.002","article-title":"Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation","volume":"114","author":"Tanjuakio","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2022.10.001_bib33","article-title":"Efficacy of early haematopoietic stem cell transplantation versus enzyme replacement therapy on neurological progression in severe Hunter syndrome: case report of siblings and literature review","volume":"32","author":"Sreekantam","year":"2022","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.pedneo.2022.10.001_bib34","first-page":"81","article-title":"Effectiveness of early hematopoietic stem cell transplantation in preventing neurocognitive decline in mucopolysaccharidosis type II: a case series","volume":"41","author":"Selvanathan","year":"2018","journal-title":"JIMD Rep"},{"key":"10.1016\/j.pedneo.2022.10.001_bib35","first-page":"S176","article-title":"Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment","volume":"vol. 15","author":"Klein","year":"1995"},{"key":"10.1016\/j.pedneo.2022.10.001_bib37","article-title":"Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: a case description and comparison with a genotype-matched control group","volume":"23","author":"K\u00f6hn","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.pedneo.2022.10.001_bib38","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.bbmt.2016.08.015","article-title":"Allogeneic hematopoietic stem cell transplantation in thirty-four pediatric cases of mucopolysaccharidosis\u2014a ten-year report from the China Children Transplant Group","volume":"22","author":"Wang","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.pedneo.2022.10.001_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.877735","article-title":"The outcome of allogeneic hematopoietic stem cell transplantation from different donors in recipients with mucopolysaccharidosis","volume":"10","author":"Qu","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pedneo.2022.10.001_bib40","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3324\/haematol.2011.058644","article-title":"Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler\u2019s syndrome after pharmacological enzyme replacement therapy","volume":"97","author":"Saif","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.pedneo.2022.10.001_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50595-1","article-title":"Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes","volume":"9","author":"Lund","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pedneo.2022.10.001_bib42","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic stem- and progenitor-cell gene therapy for Hurler syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2022.10.001_bib45","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s10038-019-0662-9","article-title":"Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future","volume":"64","author":"Chen","year":"2019","journal-title":"J Hum Genet"},{"key":"10.1016\/j.pedneo.2022.10.001_bib46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2022.10.001_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.pedneo.2022.10.001_bib48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.pedneo.2022.10.001_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40259-019-00344-7","article-title":"Vestronidase alfa: a review in mucopolysaccharidosis VII","volume":"33","author":"McCafferty","year":"2019","journal-title":"BioDrugs"},{"key":"10.1016\/j.pedneo.2022.10.001_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","article-title":"Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study","volume":"37","author":"Hendriksz","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.pedneo.2022.10.001_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2014.10.017","article-title":"First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient","volume":"114","author":"Fox","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2022.10.001_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2022.10.001_bib54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2022.07.017","article-title":"Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: results from a phase 2\/3 randomized study","volume":"137","author":"Muenzer","year":"2022","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2022.10.001_bib55","first-page":"139","article-title":"Molecular Trojan horses for blood-brain barrier drug delivery","volume":"6","author":"Pardridge","year":"2006","journal-title":"Discov Med"},{"key":"10.1016\/j.pedneo.2022.10.001_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2020.602236","article-title":"Brain delivery of nanomedicines: Trojan horse liposomes for plasmid DNA gene therapy of the brain","volume":"2","author":"Pardridge","year":"2020","journal-title":"Front Med Technol"},{"key":"10.1016\/j.pedneo.2022.10.001_bib58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A phase 2\/3 trial of Pabinafusp alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.pedneo.2022.10.001_bib59","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pedneo.2022.10.001_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2017.12.434","article-title":"Gene therapy for mucopolysaccharidoses","volume":"123","author":"Sawamoto","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pedneo.2022.10.001_bib62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fonc.2019.00297","article-title":"Gene therapy leaves a vicious cycle","volume":"9","author":"Goswami","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.pedneo.2022.10.001_bib65","first-page":"75","article-title":"Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II","volume":"10","author":"Polgreen","year":"2017","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.pedneo.2022.10.001_bib67","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses","volume":"14","author":"Piotrowska","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pedneo.2022.10.001_bib68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.curtheres.2008.04.002","article-title":"Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: an open-label, pilot study in 10 pediatric patients","volume":"69","author":"Piotrowska","year":"2008","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.pedneo.2022.10.001_bib69","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.22643","article-title":"Genistein in Sanfilippo disease: a randomized controlled crossover trial","volume":"71","author":"de Ruijter","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pedneo.2022.10.001_bib75","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2200587","article-title":"In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe\u2019s Disease","volume":"387","author":"Cohen","year":"2022","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"10.1016\/j.pedneo.2022.10.001_bib72","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"10.1016\/j.pedneo.2022.10.001_bib74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13052-018-0552-3","article-title":"Newborn screening in mucopolysaccharidoses","volume":"44","author":"Donati","year":"2018","journal-title":"Ital J Pediatr"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187595722200225X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187595722200225X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:56:30Z","timestamp":1761749790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187595722200225X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":58,"alternative-id":["S187595722200225X"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2022.10.001","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and new therapies for mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2022.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}